AMBER KERBY: Open Payments
NPI 1609460179 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,247 in 51 payments from 7 companies in 2025. Trend: 2023 $2,276 · 2024 $364 · 2025 $1,247
Food & beverage: $1,247
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $380 |
| Axsome Therapeutics, Inc. | 10 | $302 |
| ABBVIE INC. | 8 | $172 |
| Vanda Pharmaceuticals Inc. | 4 | $142 |
| Otsuka America Pharmaceutical, Inc. | 6 | $119 |
| Corium, LLC | 6 | $72 |
| Collegium Pharmaceutical, Inc. | 3 | $61 |
Products named: CAPLYTA, Auvelity, VRAYLAR, FANAPT, REXULTI, Azstarys, Jornay PM, HETLIOZ.
Industry payments across TN — which companies pay providers there.
